The Advisory Committee on Immunization Practices voted on Wednesday to agree to advise doctors that FluMist nasal is more successful in preventing flu in children ages 2-8 years old. Studies have found that children within this age group are half as likely to contract the flu if they have had the spray vaccine, rather than the shot. There is no clear difference in adults. However, not everyone supports the movement to nasal spray vaccines. According to an article in The Washington Post:
A representative of the American Academy of Pediatrics noted that FluMist is more expensive, that it cannot be used for everyone and that doctors have already ordered their vaccine doses for the fall flu season.
FluMist costs $23, shots tend to cost between $8 and $22, and while one is more expensive than the other, it is stressed that both forms of vaccine work well in preventing the flu.
Read more here- “Panel: Flu Better Than Shots for Young Kids,” (Associated Press, The Washington Post)
Olivia is a graduate of Villanova University where she studied Economics and History, minoring in Gender and Women's Studies. She also has experience working with federal legislatures on health care policy, women's issues, and Internet safety.